IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $827,753 | +1.6% | 82,037 | -0.2% | 0.04% | +59.3% |
| Q3 2022 | $815,000 | +1.1% | 82,200 | 0.0% | 0.03% | +8.0% |
| Q2 2022 | $806,000 | 0.0% | 82,200 | 0.0% | 0.02% | +13.6% |
| Q1 2022 | $806,000 | +0.9% | 82,200 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $799,000 | +0.3% | 82,200 | 0.0% | 0.02% | -18.5% |
| Q3 2021 | $797,000 | +0.3% | 82,200 | 0.0% | 0.03% | -10.0% |
| Q2 2021 | $795,000 | – | 82,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integrity Capital Management (HK) Ltd | 46,717 | $458,000 | 2.36% |
| Lynwood Capital Management Inc. | 51,400 | $504,000 | 0.54% |
| TEGEAN CAPITAL MANAGEMENT, LLC | 91,422 | $896,000 | 0.48% |
| KRYGER CAPITAL Ltd | 422,029 | $4,140,000 | 0.24% |
| BASSO CAPITAL MANAGEMENT, L.P. | 170,114 | $1,669,000 | 0.16% |
| SPRING CREEK CAPITAL LLC | 400,000 | $3,924,000 | 0.16% |
| Vestcor Inc | 400,000 | $3,924,000 | 0.14% |
| Castle Creek Arbitrage, LLC | 253,446 | $2,483,000 | 0.12% |
| ROBINSON CAPITAL MANAGEMENT, LLC | 17,881 | $175,000 | 0.12% |
| Knott David M Jr | 36,000 | $353,000 | 0.11% |